Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-877 Drug-Drug Interaction with Digoxin in Healthy Volunteers
NCT02273986Phase 1Completed
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pemafibrate in hypertriglyceridemia (2 arms). Primary endpoint: Maximum Concentration at 24 hours. Started Aug 2014; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02273986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273986.